CTN Pacific Northwest Node
The Pacific Northwest Node joined the National Drug Abuse Treatment Clinical Trials Network in January 2001, with the goal of forging partnerships to improve the quality of substance use disorder treatment and improve the lives of people affected by substance use in our region and throughout the nation. The Node is a collaboration among researchers at the University of Washington Addictions, Drug & Alcohol Institute and Washington State University, as well as affiliated community partners across Washington, California, and Alaska.
The Pacific Northwest Node is also the home of the CTN Dissemination Library, a digital library of journal articles and other publications created by and about the work of the NIDA CTN.
New CTN-0082 paper: Factors associated with PrEP awareness and use among MSM who use drugs in the Southern U.S. (December 18, 2024)
Recommended resource: Prenatal Action for Taking Health Steps (PATHS) Toolkit about medication for OUD during pregnancy. (October 28, 2024)
New resource: Extended-release injectable buprenorphine videos & factsheets for clinicians (September 12, 2024)
About Us & Directory
Read about the history & purpose of the PNW Node and find our directory of research & community partners.
Research Protocols
What CTN studies is the Pacific Northwest Node involved in? Find out here!
Community Advisory Board
Our CAB is a vital part of our work. Learn more about who they are and what they do.
Info Bites for Clinicians
Short educational videos (other materials coming soon!) for clinicians.
Principal Investigators
Mary Hatch, PhD
Addictions, Drug & Alcohol Institute, University of Washington
hatchm@uw.edu
John Roll, PhD
Elson S. Floyd College of Medicine, Washington State University
johnroll@wsu.edu
